Delivering Value To Those We Serve

Overview

Recent News

Date Title and Summary
Toggle Summary Activbiotics and De[pomed Announce Aagreement to Develop New Product for the Treatment of Acute and Chronic Gastrointestinal Diseases
Cambridge, MA and Menlo Park, CA, October 15, 2002. -- ActivBiotics, Inc. and DepoMed, Inc. (AMEX:DMI) today announced a memorandum of understanding under which DepoMed will develop a controlled-release oral tablet which delivers ActivBiotics' broad spectrum lead compound, rifalazil, to the
Toggle Summary AMEX Approves Depomed's Continued Listings Plan
MENLO PARK, Calif. – September 20, 2002 – DepoMed today announced that on September 17, 2002, the Company received notice from the staff of the American Stock Exchange that the AMEX had accepted the Company's plan to regain compliance with AMEX listing standards and had granted the Company an
Toggle Summary Appeals Court Upholds Depomed Patents Asserted against Purdue Pharma
NEWARK, Calif. , March 24, 2016 (GLOBE NEWSWIRE) -- Depomed (NASDAQ:DEPO) announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed the decisions of the Patent Trial and Appeal Board of the United States Patent and Trademark Office (PTAB) confirming the patentability of

Upcoming Events

There are currently no events to display.

Recent SEC Filings

Filing date Description Form Filing Group View

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT

IR Contact

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com
 

Independent Registered Public Accounting Firm

Ernst & Young LLP
Palo Alto, CA
 

Investor Relations Contact

John B. Thomas
SVP, Investor Relations & Corporate Communications
jthomas@assertiotx.com